Business Description

UnitedHealth Group Incorporated is an American multinational managed healthcare and insurance company. It operates through two primary segments: UnitedHealthcare, which provides health insurance and benefits, and Optum, which offers technology-enabled health services, care delivery, and pharmacy benefit management. As the largest healthcare company in the world by revenue, it holds a dominant position in the U.S. health insurance market.

Everything on UnitedHealth Group Incorporated

Revenue (FY2025) $447.57B
YoY growth +11.8%
Operating margin 4.2%
Direction Expanding
Gross margin —
Net margin 2.9%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Charles Baker — Independent Director View full profile ↗ Timothy Flynn — Independent Director View full profile ↗ Paul Garcia — Independent Director View full profile ↗ Kristen Gil — Independent Director View full profile ↗ Scott Gottlieb, M.D. — Independent Director View full profile ↗ Stephen Hemsley — Chair and Chief Executive Officer View full profile ↗ F. William McNabb III — Lead Independent Director View full profile ↗ Valerie Montgomery Rice, M.D. — Independent Director View full profile ↗ John Noseworthy, M.D. — Independent Director View full profile ↗ Wayne DeVeydt — Chief Financial Officer View full profile ↗ Patrick Conway, M.D. — Chief Executive Officer, Optum View full profile ↗ Erin McSweeney — Executive Vice President and Chief People Officer View full profile ↗ Timothy Noel — Chief Executive Officer, UnitedHealthcare View full profile ↗ Thomas Roos — Senior Vice President and Chief Accounting Officer View full profile ↗ Christopher Zaetta — Executive Vice President, Chief Legal Officer and Corporate Secretary View full profile ↗ Dennis Stankiewicz — Chief Accounting Officer View full profile ↗ Andrew Witty — Former Chief Executive Officer View full profile ↗ John Rex — Former President and Chief Financial Officer View full profile ↗

Share Repurchase Program

Total authorized
In June 2024 the Board authorized repurchase of up to 35 million shares of common stock, in addition to all remaining shares authorized under the Board's 2018 renewal of the program (originally adopted November 1997); no established expiration date.
Remaining (Three months ended March 31, 2026 (10-Q, Reg S-K Item 703); FY2025 for annual spend (10-K).)
19.3 million shares remaining authorized as of March 31, 2026 (10-Q); 21 million shares as of December 31, 2025 (10-K).
Latest FY repurchased
$5.5 billion aggregate cost for 12 million shares repurchased in fiscal year 2025 ($5,482 million aggregate cost; $5,545 million cash paid).

Customer Concentration

Premium revenues from CMS (the Centers for Medicare & Medicaid Services) represented 44% of UnitedHealth Group's total consolidated revenues for the year ended December 31, 2025, most of which were generated by UnitedHealthcare Medicare & Retirement.

Recent SEC Filings

2026-06-05 Shareholder vote results View filing ↗
2026-05-11 Regulation FD disclosure View filing ↗
2026-04-21 Reported quarterly results View filing ↗
2026-03-09 Regulation FD disclosure View filing ↗
2026-03-02 Leadership change (directors/officers) View filing ↗
2026-02-25 Leadership change (directors/officers) View filing ↗
2026-01-27 Reported quarterly results View filing ↗
2026-01-12 Regulation FD disclosure View filing ↗
2025-11-21 Leadership change (directors/officers) View filing ↗
2025-11-13 Amended charter/bylaws View filing ↗
2025-11-07 Regulation FD disclosure View filing ↗
2025-10-28 Reported quarterly results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.